SCHOTT Pharma
Alexander Koch currently serves as Manager Information Technology R&D, Production and Quality at SCHOTT Pharma since August 2022. Prior to this role, Alexander held positions such as Project Lead S/4HANA R&D, Production and Quality at SCHOTT from January 2020 to September 2022, Manager at Deloitte Consulting from May 2018 to December 2019, and Senior Consultant at Capgemini from January 2014 to February 2018. Alexander's earlier career includes roles as Senior Consultant at Aseaco AG, Consultant at Logica, and Associate Consultant at CSC - Computer Sciences Corporation, beginning in August 2003. Educational qualifications include a Bachelor of Arts in Betriebswirtschaftslehre from PFH Göttingen, a Betriebswirt (VWA) in Betriebswirtschaftslehre from VWA Mainz, and a Fachinformatiker in Anwendungsentwicklung from CSC Ploenzke / IHK Wiesbaden.
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social